Kathleen Rickard
Chief Tech/Sci/R&D Officer bij VERONA PHARMA PLC
Vermogen: 17 M $ op 31-03-2024
Profiel
Kathleen Rickard is currently the Chief Medical Officer at Verona Pharma Plc since 2019.
Prior to this, she worked at Aerocrine AB from 2011 to 2019 as the Chief Medical & Compliance Officer.
She also worked at GSK Plc as the VP-Clinical Development & Medical Affairs.
Dr. Rickard holds a doctorate degree from Hahnemann University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
VERONA PHARMA PLC
1.80% | 05-02-2024 | 8 656 336 ( 1.80% ) | 17 M $ | 31-03-2024 |
Actieve functies van Kathleen Rickard
| Bedrijven | Functie | Begin |
|---|---|---|
| VERONA PHARMA PLC | Chief Tech/Sci/R&D Officer | 01-02-2019 |
Eerdere bekende functies van Kathleen Rickard
| Bedrijven | Functie | Einde |
|---|---|---|
| AEROCRINE AB | Compliance Officer | 01-01-2019 |
| GSK PLC | Corporate Officer/Principal | - |
Opleiding van Kathleen Rickard
| Hahnemann University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| GSK PLC | Health Technology |
| VERONA PHARMA PLC | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Aerocrine AB
 Aerocrine AB Electronic Equipment/InstrumentsElectronic Technology Aerocrine AB operates as a specialty pharmaceutical company focused on respiratory disease. The company was founded by Lars E. Gustafsson, Jon Lundberg, Kjell Alving, and Eddie Weitzberg in November 1997 and is headquartered in Uppsala, Sweden. | Electronic Technology |
